Related references
Note: Only part of the references are listed.Enzalutamide, an androgen receptor signaling inhibitor, induces tumor regression in a mouse model of castration-resistant prostate cancer
Javier Guerrero et al.
PROSTATE (2013)
Surgical Stress Promotes Tumor Growth in Ovarian Carcinoma
Jeong-Won Lee et al.
CLINICAL CANCER RESEARCH (2009)
Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
Chris Tran et al.
SCIENCE (2009)
Pathological changes of high-grade prostatic intraepithelial neoplasia and prostate cancer after monotherapy with bicalutamide 150 mg
Vincenzo Scattoni et al.
BJU INTERNATIONAL (2006)
The norepinephrine-driven metastasis development of PC-3 human prostate cancer cells in BALB/c nude mice is inhibited by β-blockers
D Palm et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Androgen deprivation therapy for prostate cancer: Current status and future prospects
H Miyamoto et al.
PROSTATE (2004)
Bicalutamide as immediate therapy either alone or as adjuvant to standard care of patients with localized or locally advanced prostate cancer: First analysis of the early prostate cancer program
WA See et al.
JOURNAL OF UROLOGY (2002)
The development of androgen-independent prostate cancer
BJ Feldman et al.
NATURE REVIEWS CANCER (2001)
Share Paper
